Splicing choice from ten variant exons establishes CD44 variability - PubMed (original) (raw)
Splicing choice from ten variant exons establishes CD44 variability
C Tölg et al. Nucleic Acids Res. 1993.
Free PMC article
Abstract
The enormous heterogeneity of the surface protein designated CD44 is in part due to posttranslational modification, and in part due to differential splicing. Alternative splicing occurs within one particular region encoding the extracellular portion of the protein. Comparison of various cDNA clones with different 'inserts' in this variable region with sequences of genomic clones from the mouse has revealed the existence of at least ten exons from which sequences are chosen by alternative splicing. Various combinations of these exons account for the tremendous heterogeneity of CD44 molecules expressed in different tissues, and in progressing tumor cells. The existence of different isoforms of CD44 suggests a broad spectrum of yet unknown physiologic functions.
Similar articles
- The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.
Cooper DL, Dougherty G, Harn HJ, Jackson S, Baptist EW, Byers J, Datta A, Phillips G, Isola NR. Cooper DL, et al. Biochem Biophys Res Commun. 1992 Jan 31;182(2):569-78. doi: 10.1016/0006-291x(92)91770-q. Biochem Biophys Res Commun. 1992. PMID: 1734871 - Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Screaton GR, et al. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12160-4. doi: 10.1073/pnas.89.24.12160. Proc Natl Acad Sci U S A. 1992. PMID: 1465456 Free PMC article. - Regulation of alternative splicing.
McKeown M. McKeown M. Genet Eng (N Y). 1990;12:139-81. doi: 10.1007/978-1-4613-0641-2_9. Genet Eng (N Y). 1990. PMID: 1369274 Review. No abstract available. - Lymphocyte homing receptors.
Hu MC, Siegelman MH, Holzmann B, Crowe DT, Weissman IL. Hu MC, et al. Cold Spring Harb Symp Quant Biol. 1992;57:291-308. doi: 10.1101/sqb.1992.057.01.034. Cold Spring Harb Symp Quant Biol. 1992. PMID: 1339666 Review. No abstract available.
Cited by
- CD44 and its implication in neoplastic diseases.
Xu Y, Bai Z, Lan T, Fu C, Cheng P. Xu Y, et al. MedComm (2020). 2024 May 23;5(6):e554. doi: 10.1002/mco2.554. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38783892 Free PMC article. Review. - miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma.
Hanif F, Zhang Y, Dube C, Gibert MK Jr, Saha S, Hudson K, Marcinkiewicz P, Kefas B, Guessous F, Abounader R. Hanif F, et al. Int J Mol Sci. 2023 May 26;24(11):9326. doi: 10.3390/ijms24119326. Int J Mol Sci. 2023. PMID: 37298284 Free PMC article. - A New Model of Esophageal Cancers by Using a Detergent-Free Decellularized Matrix in a Perfusion Bioreactor.
Brennan J, Lu ML, Kang Y. Brennan J, et al. Bioengineering (Basel). 2023 Jan 11;10(1):96. doi: 10.3390/bioengineering10010096. Bioengineering (Basel). 2023. PMID: 36671668 Free PMC article. - Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer.
Otaegi-Ugartemendia M, Matheu A, Carrasco-Garcia E. Otaegi-Ugartemendia M, et al. Cancers (Basel). 2022 Mar 11;14(6):1457. doi: 10.3390/cancers14061457. Cancers (Basel). 2022. PMID: 35326607 Free PMC article. Review. - CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A. Hassn Mesrati M, et al. Biomolecules. 2021 Dec 9;11(12):1850. doi: 10.3390/biom11121850. Biomolecules. 2021. PMID: 34944493 Free PMC article. Review.
References
- Science. 1992 Jul 31;257(5070):682-5 - PubMed
- J Biol Chem. 1992 Mar 5;267(7):4732-9 - PubMed
- EMBO J. 1987 May;6(5):1251-7 - PubMed
- EMBO J. 1987 May;6(5):1259-64 - PubMed
- J Cell Biol. 1987 Aug;105(2):983-90 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous